Stocky turns companies like XERS into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. Xeris shows solid growth momentum (Growth Compounder 64.8/100 driven by Gvoke and Keveyis expansion), but Leadership Alignment (38.3/100) and middling Value metrics (P/E 37.1) temper the case. Critical vulnerability: Gvoke relies on three single-source suppliers (Bachem for API, Pyramid for drug product, SHL for assembly), and Keveyis depends entirely on Taro—whose agreement renews March 2027 with reversion rights to regulatory assets. Supply concentration and contract dependency outwe
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for XERS:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 56/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates XERS (XERS) at 56/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. Xeris shows solid growth momentum (Growth Compounder 64.8/100 driven by Gvoke and Keveyis expansion), but Leadership Alignment (38.3/100) and middling Value metrics (P/E 37.1) temper the case. Critical vulnerability: Gvoke relies
XERS's current Stocky Verdict is 56/100, placing it in the "Cautious" band. This composite combines a 65/100 Compounder score, 38/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for XERS yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
XERS scores 38/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
XERS's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to XERS.
Sign up free and unlock the full analysis on XERS — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for XERS in the app.
